🔎 Trials Near Me

Akèy › Sarkom tisi mou › Kalifòni

Etid klinik pou Sarkom tisi mou nan Kalifòni

41 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Children's Hospital Los Angeles, Los Angeles
  • University of California at Los Angeles, Los Angeles
Ap rekriteFaz 1/2
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07229313

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • Stanford University, Palo Alto
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • Precision NextGen Oncology and Research, Beverly Hills
  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
  • ak 3 plis
Ap rekriteFaz 1
Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05711615

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

  • University of California San Francisco, San Francisco
Ap rekriteFaz 1
Laj 5 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT06156410

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • ak 20 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069

Actinium Therapy for Late-stage Aggressive Sarcomas

  • UCLA, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • University of California, San Francisco, San Francisco
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT06975293

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • USC/Norris Comprehensive Cancer Center, Los Angeles
  • Sarcoma Oncology Center, Santa Monica
  • University of California Los Angeles (UCLA) - Santa Monica Cancer Care, Santa Monica
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06263231

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06242470

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • ak 6 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07059884

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07628634

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  • Zai Lab Site 02003, Los Angeles
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07374848

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

  • Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 17, 2026 · NCT07064018

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

  • University of California, Davis, Sacramento
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06103669

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  • KP Southern California - Department of Research & Evaluation, Pasadena
Ap rekrite
Laj 21 a 45 · Tout sèks · Mizajou Jul 6, 2026 · NCT07406087

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Jun 22, 2026 · NCT07650656

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

  • Precision NextGen Oncology and Research Center, Beverly Hills
  • Sarcoma Oncology Center, Santa Monica
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06789172

5-Day Preoperative Radiation for Soft Tissue Sarcoma

  • Stanford University, Palo Alto
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06087861

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • St Joseph Heritage Healthcare, Santa Rosa
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

  • Stanford University, Palo Alto
Ap rekriteFaz 1
Laj 2 a 30 · Tout sèks · Mizajou May 7, 2026 · NCT06500819

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Beckman Research Institute of City of Hope, Duarte
  • VA Medical Center, Fresno, Fresno
  • Santa Clara Valley Medical Center, Fruitdale
  • ak 5 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734

Prospective Registry of Histotripsy for Soft Tissue Tumors

  • University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT07470008

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 10, 2026 · NCT02701153

Phase II Trial of Lung Chemoemobolization

  • City of Hope Medical Center, Duarte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT05672108

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

  • Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 3, 2026 · NCT07447050

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • Sarcoma Oncology Center, Santa Monica
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT03016819

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's Hospital of Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
Ap rekriteFaz 1/2
Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • City of Hope, Duarte
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

  • University of Southern California - Norris Cancer Center, Los Angeles
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 26, 2025 · NCT06942442

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • University of Southern California, Los Angeles
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

  • City of Hope, Duarte
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
  • Stanford Hospital & Clinics, Stanford
Ap rekriteFaz 1/2
Laj 15 ak plis · Tout sèks · Mizajou Aug 12, 2025 · NCT06298916

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

  • Sarcoma Oncology Center, Santa Monica
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 24, 2025 · NCT03886311

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

  • Sarcoma Oncology Research Center, Santa Monica
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Feb 24, 2025 · NCT03138161

BostonGene and Exigent Genomic INsight Study

  • Stockton Hematology Oncology Medical Group, Stockton
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2025 · NCT06272864

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.